🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and assertions of next-day British shipping. Sellers promote the substance there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to users administering substances of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has taken down problematic content and prohibited related keywords and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, filled with images of slimming results, glowing testimonials and detailed guides for preparing or administering at residence.

After minutes of entering one community, a seller posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Information and Costs

Inside these communities, posts show black plastic parcels with postal service labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram stated it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they can’t verify. Although the research behind this drug is valid, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has previously encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.